{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:38:06Z","timestamp":1773866286238,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1136\/ijgc-00009577-200602001-00038","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T09:54:28Z","timestamp":1551866068000},"page":"236-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S1","title":["Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer"],"prefix":"10.1016","volume":"16","author":[{"given":"H.T.","family":"See","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bueso-Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-00009577-200602001-00038_bib1","first-page":"435","article-title":"Therapy-related leukemia and myelo-dysplastic syndrome","volume":"14","author":"Kantarjian","year":"1987","journal-title":"Semin Oncol"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0889-8588(05)70340-3","article-title":"Therapy-related myeloid leukemia","volume":"10","author":"Thirman","year":"1996","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib3","first-page":"256","article-title":"Secondary myelodysplastic syndromes and leukemias","volume":"1","author":"Giles","year":"1994","journal-title":"Curr Opin Hematol"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib4","first-page":"937","article-title":"The incidence of secondary leukemias","volume":"84","author":"Leone","year":"1999","journal-title":"Haematologica"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/10428190109057981","article-title":"Therapy related leukemias: susceptibility, prevention and treatment","volume":"41","author":"Leone","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib6","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood.V72.4.1333.1333","article-title":"Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine","volume":"72","author":"Larson","year":"1988","journal-title":"Blood"},{"issue":"Suppl. 14","key":"10.1136\/ijgc-00009577-200602001-00038_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.seminoncol.2004.11.007","article-title":"Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers","volume":"31","author":"Muggia","year":"2004","journal-title":"Semin Oncol"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/bjc.1987.201","article-title":"Second primary malignancy after Hodgkin\u2019s disease, ovarian cancer and cancer of the testis: a population-based cohort study","volume":"56","author":"Coleman","year":"1987","journal-title":"Br J Cancer"},{"issue":"Suppl. 7","key":"10.1136\/ijgc-00009577-200602001-00038_bib9","first-page":"11","article-title":"Chemotherapy for advanced ovarian cancer: overview of randomized trials","volume":"27","author":"Thigpen","year":"2000","journal-title":"Semin Oncol"},{"issue":"Suppl. 2","key":"10.1136\/ijgc-00009577-200602001-00038_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1081\/CNV-200030115","article-title":"First-line therapy for ovarian carcinoma: what\u2019s next?.","volume":"22","author":"Thigpen","year":"2004","journal-title":"Cancer Invest"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0006-291X(85)91882-0","article-title":"Kinetics of the reaction of cisplatinum compounds with DNA in vitro","volume":"133","author":"Butour","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1634\/theoncologist.3-1-15","article-title":"New perspectives on an old friend: optimizing carboplatin for the treatment of solid tumors","volume":"3","author":"Alberts","year":"1998","journal-title":"Oncologist"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/92.9.699","article-title":"Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results","volume":"92","author":"Piccart","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib15","first-page":"2168","article-title":"Cell cycle-mediated drug resistance: an emerging concept in cancer therapy","volume":"7","author":"Shah","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM199902043400504","article-title":"Risk of leukemia after platinum-based chemotherapy for ovarian cancer","volume":"340","author":"Travis","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib17","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.leu.2401552","article-title":"Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy","volume":"13","author":"Seymour","year":"1999","journal-title":"Leukemia"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib18","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/sj.leu.2402549","article-title":"Erythroleukemia: a need for a new definition","volume":"16","author":"Park","year":"2002","journal-title":"Leukemia"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic asso-ciations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bmt.1700971","article-title":"Bone marrow trans-plantation for therapy-related myelodysplasia: comparison with primary myelodysplasia","volume":"20","author":"Ballen","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1136\/ijgc-00009577-200602001-00038_bib21","series-title":"Ovarian Cancer: Controversies in Treatment.","first-page":"178","article-title":"Importance of dose intensity in ovarian cancer.","author":"Vasey","year":"1998"},{"issue":"Suppl. 1","key":"10.1136\/ijgc-00009577-200602001-00038_bib22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ijgc-00009577-200107001-00013","article-title":"High dose chemotherapy in ovarian cancer","volume":"11","author":"Pujade-Lauraine","year":"2001","journal-title":"Int J Gynecol Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24191724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24191724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-00009577-200602001-00038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:10:56Z","timestamp":1753233056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24191724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":22,"aliases":["10.1111\/j.1525-1438.2006.00491.x"],"alternative-id":["S1048891X24191724"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200602001-00038","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200602001-00038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Blackwell Publishing Ltd.","name":"copyright","label":"Copyright"}]}}